Cargando…
Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer
This study compared the diagnostic value of molybdenum target and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in different types of breast cancer. A retrospective analysis was performed on 120 female patients with breast cancer admitted to The First Affiliated Hospital of Zhengzho...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732951/ https://www.ncbi.nlm.nih.gov/pubmed/31516606 http://dx.doi.org/10.3892/ol.2019.10746 |
_version_ | 1783449895719403520 |
---|---|
author | Hu, Ying Zhang, Yan Cheng, Jingliang |
author_facet | Hu, Ying Zhang, Yan Cheng, Jingliang |
author_sort | Hu, Ying |
collection | PubMed |
description | This study compared the diagnostic value of molybdenum target and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in different types of breast cancer. A retrospective analysis was performed on 120 female patients with breast cancer admitted to The First Affiliated Hospital of Zhengzhou University from February 2015 to October 2017. All of them underwent DCE-MRI and molybdenum target examination. Postoperatively, the pathological tissues were examined to determine their molecular typing. The sensitivity and diagnostic coincidence rates of Luminal-B breast cancer with different molecular types diagnosed by molybdenum target combined with DCE-MRI were significantly higher than those of molybdenum target or DCE-MRI alone. There were no statistical differences in sensitivity and diagnostic coincidence rates of breast cancer with different molecular types diagnosed by molybdenum target or DCE-MRI alone between the two groups (P>0.05). Molybdenum target combined with DCE-MRI in the diagnosis of different molecular types of breast cancer is better than the single imaging screening, which is of great clinical significance in the development of individualized comprehensive treatment for breast cancer patients and worthy of wide promotion in clinical practice. |
format | Online Article Text |
id | pubmed-6732951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-67329512019-09-12 Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer Hu, Ying Zhang, Yan Cheng, Jingliang Oncol Lett Articles This study compared the diagnostic value of molybdenum target and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in different types of breast cancer. A retrospective analysis was performed on 120 female patients with breast cancer admitted to The First Affiliated Hospital of Zhengzhou University from February 2015 to October 2017. All of them underwent DCE-MRI and molybdenum target examination. Postoperatively, the pathological tissues were examined to determine their molecular typing. The sensitivity and diagnostic coincidence rates of Luminal-B breast cancer with different molecular types diagnosed by molybdenum target combined with DCE-MRI were significantly higher than those of molybdenum target or DCE-MRI alone. There were no statistical differences in sensitivity and diagnostic coincidence rates of breast cancer with different molecular types diagnosed by molybdenum target or DCE-MRI alone between the two groups (P>0.05). Molybdenum target combined with DCE-MRI in the diagnosis of different molecular types of breast cancer is better than the single imaging screening, which is of great clinical significance in the development of individualized comprehensive treatment for breast cancer patients and worthy of wide promotion in clinical practice. D.A. Spandidos 2019-10 2019-08-14 /pmc/articles/PMC6732951/ /pubmed/31516606 http://dx.doi.org/10.3892/ol.2019.10746 Text en Copyright: © Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Hu, Ying Zhang, Yan Cheng, Jingliang Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer |
title | Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer |
title_full | Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer |
title_fullStr | Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer |
title_full_unstemmed | Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer |
title_short | Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer |
title_sort | diagnostic value of molybdenum target combined with dce-mri in different types of breast cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732951/ https://www.ncbi.nlm.nih.gov/pubmed/31516606 http://dx.doi.org/10.3892/ol.2019.10746 |
work_keys_str_mv | AT huying diagnosticvalueofmolybdenumtargetcombinedwithdcemriindifferenttypesofbreastcancer AT zhangyan diagnosticvalueofmolybdenumtargetcombinedwithdcemriindifferenttypesofbreastcancer AT chengjingliang diagnosticvalueofmolybdenumtargetcombinedwithdcemriindifferenttypesofbreastcancer |